<?xml version="1.0" encoding="UTF-8"?>
<ref id="B206-pharmaceuticals-14-00381">
 <label>206.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Behl</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kaur</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Bungau</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kumar</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Uddin</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Kumar</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Pal</surname>
    <given-names>G.</given-names>
   </name>
   <name name-style="given-only">
    <given-names>Sahil</given-names>
   </name>
   <name>
    <surname>Shrivastava</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Zengin</surname>
    <given-names>G.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions</article-title>
  <source>Life Sci.</source>
  <year>2020</year>
  <volume>257</volume>
  <fpage>118075</fpage>
  <pub-id pub-id-type="doi">10.1016/j.lfs.2020.118075</pub-id>
  <pub-id pub-id-type="pmid">32653522</pub-id>
 </element-citation>
</ref>
